Litigation Details for AstraZeneca LP v. Mylan Pharmaceuticals Inc. (D. Del. 2015)
AstraZeneca LP v. Mylan Pharmaceuticals Inc. (D. Del. 2015)
| Docket | ⤷ Start Trial | Date Filed | 2015-10-30 |
| Court | District Court, D. Delaware | Date Terminated | 2018-02-06 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Patents | 6,251,910; 6,525,060; 7,250,419; 7,265,124; 8,425,934 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in AstraZeneca LP v. Mylan Pharmaceuticals Inc.
Details for AstraZeneca LP v. Mylan Pharmaceuticals Inc. (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-10-30 | External link to document | |||
| 2015-10-30 | 30 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,251,910; 6,525,060; 7,250,419…2015 6 February 2018 1:15-cv-00999 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
